Uppsala MedTech Science and Innovation Day 2024
4th Swedish Medicinal Chemistry Symposium
Quality register for research
Implementing new advanced diagnostics and treatment in Sweden
Environmental, Social and Governance (ESG) is highly topical
Incorporating ESG criteria in your business can offer several strategic advantages, including strengthening competitiveness, reducing risks, and creating a sustainable foundation for successful growth.
Lab & Diagnostics of the Future
Future Health: Blood proteomics – new opportunities for precise diagnostics and disease prediction
Technological leaps during the last few years have allowed for determining protein profiles from a small drop of blood. Large-scale protein analyses of blood samples reveal new biomarkers for different diseases, indicating that blood profiling is being developed into a powerful tool for monitoring health and disease.
Blood proteomics – new opportunities for precise diagnostics and disease prediction
Recent advances in the proteomic analyses of human blood have revealed new insights and tools for monitoring disease and health. SomaLogic, who recently merged with Standard BioTools has been one of the major contributors to this rapid development. Stephen A. Williams is Chief Medical Officer at Somalogic (now Standard BioTools). He was also one of the speakers at Stockholm Science City's panel discussion Future Health, on March 19.